OCA: Record earnings, strong sales, lower debt, and robust ESG progress despite market headwinds

About this update from Oceania Healthcare Ltd.

Record FY26 results with 34% growth in proforma NPAT and 20% in EBITDA, improved sales and cost discipline, reduced net debt, and strong ESG progress. No dividend declared; focus remains on cash generation and disciplined growth amid ongoing market and climate risks.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Oceania Healthcare Ltd.